Tafalgie Therapeutics expands R&D capabilities and moves into new premises Tafalgie Therapeutics, a biopharmaceutical research company specialised in the development of treatments capable of relieving and preventing the onset of acute and chronic pain (inflammatory, post-operative, neuropathic) without side effects, announces that its teams are moving today to its new site in Luminy, Marseille, France, […]

Lire la suite
Visit our contact page